Volume 25, Issue 1 - Authors and Authorship
Authorship of clinical trial documents
Author: Raquel Billiones
Abstract
Authorship of publications has been the subject of much public debate; however, authorship of clinical trial documents such as clinical study protocols, clinical study reports, investigator’s brochures and inform ed consent forms has not really been given much attention. This article looks at the common practices of authorship attribution and signing off on these documents and examines what the ICH guidelines, on which their contents are based, say about these issues. The implications of the EMA Policy 0070 on clinical trial disclosure are discussed.
Keywords:
authorship
Download the full article
References
- ICH E6 (R1) Guideline 1996. Guideline for Good Clinical Practice.
- ICH E6 (R2) Guideline 2015. Integrated Addendum to ICH E6 (R1): Guideline for Good Clinical Practice.
- EMA Policy 0070 02 October 2104. Policy on Publication of Clinical Data for Medicinal Products for Human Use.
- EMA 07 September 2015. Key aspects related to the submission of clinical reports for the purpose of publication in accordance with EMA Policy 0070.
- ICH E3 Guideline 1997. Structure and Content of Clinical Study Reports.
- ICH E3 Guideline 2012. Structure and Content of Clinical Study Reports Questions & Answers (R1).
- EMA-CPMP 2001. Note for Guidance on Coordinating Investigator Signature of Clinical Study Reports.
Visit the EMWA website
Search
Articles
Authors and Authorship
Letter from the Editor
President’s Message
Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)
The sun never sets on transparency
GPP3 – what is it, why is it necessary and what is new?
Attribution, advocacy, disposable authors, corporate ghosts and cultural assimilation: new themes in the ethical critique of commercial medical literature
Perspective from a leading scientific author: An interview with Professor Ruth Roberts on authors and authoring
Authorship of clinical trial documents
Project management in medical publication writing: A less explored avenue in pharmaceutical companies and clinical research organisations
Never say never! Returning to full-time employment after freelancing
Fifth EMWA freelance business survey
Journal Watch
In the Bookstores
The Webscout
Regulatory Writing: Authorship issues in regulatory documents
English Grammar and Style
Medical Communication
Lingua Franca and Beyond
Gained in Translation
Medical Writing Teaching
Profile: An interview with Phil Leventhal
EMWA’s 2016 Webinar Programme
Out on our own
Member Login
Links
Editoral Board
Editor-in-Chief:
- Phillip Leventhal (4Clinics, Lyon, France)
Co-Editor:
- Evguenia Alechine (Epsilon Scientific Communication, Buenos Aires, Argentina)
- Stephen Gilliver (TFS Trial Form Support, Lund, Sweden)
Managing Editor
- Victoria White (Tampa, Florida, USA) Email: MEW@emwa.org
show all +
Associate Editors:
- Anuradha Alahari (PAREXEL International, Paris, France)
- Raquel Billiones (Clinipace, Zurich, Switzerland)
- Barbara Grossman (Hawkeye Medical Limited, Berkshire, UK)
- Joselita T Salita (Freelance, Bremen, Germany)
- Nathan Susnik (Hanover Medical School, Hanover, Germany)
- Clare (Chi-Chih) Chang
- Jonathan Pitt
Section Editors:
- Alison McIntosh (ICON Clinical Research, Hampshire, UK)
- Wendy Kingdom (Wendy Kingdom Ltd., Dulverton, UK)
- Lisa Chamberlain-James (Trilogy Writing and Consulting, Norfolk, UK)
- Maria Koltowska-Haggstrom (Proper Medical Writing Warsaw, Poland)
- Laura Collada Ali (Teksema, Cogne, Italy)
- Hervé Maisonneuve (Freelance, Lyon, France)
- Satyen Shenoy (Describe Scientific Writing & Communications, Cologne, Germany)
- Claire Gudex (Klinisk Institut, Odense, Denmark)
- Beatrix Doerr
- Sam Hamilton (Newcastle Upon Tyne, UK)
Ad-hoc Editors:
- Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)
Editor Emeritus:
- Elise Langdon-Neuner (Medical University of Vienna, Austria)